This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Preliminary data*, released on request from the Pennsylvania State Police Uniform Crime Reporting System, reveals that overall arrests for marijuana possession showed a decline in 2019. The new data shows 19,990 adults arrested for the same offense in 2019. cannabis arrest data since 2008. cannabis arrest data since 2008.
Rescheduling would ease those research barriers, improving access to data and education around the plant and opening the door to fully explore the medical benefits cannabis could provide. Next steps for cannabis rescheduling This proposed policy change is just that — a proposal.
The 144-page report, compiled by the Cannabis Regulation Oversight Office (CROO), incorporates data from several state departments. These rules bring further clarity and transparency to IDFPR operations by laying out policies and procedures in a clear and concise way.
According to data from the Virginia Criminal Sentencing Commission, more than 15,000 people were convicted for a first or second marijuana possession offense from July 2018 to June 2019. It’s well past time that we stop doing damage to people’s employment prospects, educational opportunities, and parental rights.
First off, I want to thank you for being an active member of the cannabis reform movement and I am proud to tell you that we have never been closer to ending the counterproductive and cruel policy of marijuana criminalization than we are right now.
According to data from the Virginia Criminal Sentencing Commission, more than 15,000 people were convicted for a first or second marijuana possession offense from July 2018 to June 2019. It’s well past time that we stop doing damage to people’s employment prospects, educational opportunities, and parental rights.
Today, we stood with Representatives Tulsi Gabbard and Don Young as they introduced the Ending Federal Prohibition Act and Marijuana Data Collection Act. This is not just good policy, but good politics. As long as marijuana remains a Schedule I substance, federal policy remains ignorant of this fact.
Those without the means to defend themselves from the state bear the greatest burden and lifelong consequences of this ongoing failed federal policy. Millions of Americans have suffered from the lifelong collateral consequences of criminal prohibition, making it harder for them to find a job, obtain housing, and access higher education.”
Contrary to some narratives of decline, recent data reveals a more nuanced pictureone of evolution, resilience, and an urgent need for continued support. MPAA) the states leading voice for patient rights and cannabis policy reform. Outdated Regulations and Policy Stagnation: The medical program cannot thrive under outdated rules.
Legalizing cannabis doesn’t undo past arrests, and record expungement doesn’t make up for the years and decades of fewer educational, employment, and other related opportunities as a result of that drug arrest,” Hudak states. In order to do so, they made use of data from 37 states between 2000 and 2019.
New York took the first step towards decriminalization at the state level in 1977, and further expanded on their decriminalization policies this year. ” Meanwhile, under the antiquated policy of absolute criminal prohibition, New Jersey is seeing a record number of citizens arrested for cannabis. “Enough is enough. .
Unfortunately, legislative intransigence regarding how best to create a regulatory framework has resulted in, at least for now, a continuation of the failed policy of marijuana criminalization in the Garden State.” “Governor Murphy has shown real leadership in driving this issue. “This fight is not over.
New Frontier Data say that they recently presented preliminary findings to the Zimbabwean government while working in collaboration with other regulators in the region to finalize what will be the first “rigorous assessments of both risks and opportunities of hemp cultivation in Africa.” Regulation , Hoban Law Group (U.S.).
Roc NORML is dedicated to educating the public about the benefits of responsible cannabis use and we look forward to continuing these conversations with local law enforcement. Please visit www.rocnorml.org for more information about how you can get involved and follow ROC NORML on Facebook and Twitter. .
Although the UK recently severed its ties with the European Union, the FSA has opted to align its policy with that of the European Food Safety Authority (“ EFSA ”). Following the March 31, 2021 deadline, only products for which a valid application has been submitted will be allowed to remain on the market. borders, too.
“New Frontier Data was the first firm to identify and address the need for data in what is now a global cannabis market. We have spent over five years building the only cannabis Big Data technology platform that is able to ingest, scrub, process and report millions of data points.”
Physicians and other healthcare professionals will need to improve their cannabis education in order to objectively answer patient questions and concerns, administer cannabis-based therapeutic programs and write cannabis prescriptions as well as assist with a necessary shift in attitude towards cannabis. . The Medical Cannabis Institute.
Director of Policy (Deputy Director, NS) #10901. The Policy Director will also oversee the development and implementation of the Office’s public health educational campaign as well as the monitoring, surveillance, and reporting on key metrics related to the impacts of cannabis legalization. Employment Type. Appointment.
The New Jersey State Policy Lab at Rutgers University has released a first-of-its-kind report examining health, education, and law enforcement factors related to marijuana usage. The goal is to use the data for comparative analysis over time to help shape state policy. The Rutgers Press Release. NJSPL-Cannabis-Feb2022.
The nature of the position involves designing application receipt and review processes, review of detailed license and renewal applications, preparation of complaints cases for investigations, preparation of investigations cases for disposition, and oversight of vendor data systems for complex laboratory, seed-to-sale tracking, and complaints.
This has led medical and legal professionals to draft and base their policies on individual studies that do not truly show conclusive results. Researchers noted the reason for this systematic and critical review is due to the “limited data demonstrating pronounced negative effects of prenatal cannabis exposure.”
Whitney Economics has announced a partnership with cutting-edge cannabis policy firm Square Root Group, LLC to offer full-scale economic analysis and policy solutions to improve the performance of U.S. While the federal debate continues, the diversity of policy approaches across 37 legal cannabis states + D.C. Press Release.
Another first of its kind in the country, the DPMPRP collects data and advises policymakers in Denver on the effects that loosening restrictions around the possession and use of psilocybin might have on the community. First responders in Denver, Colorado, will soon have another tool to support their community: psychedelic harm reduction.
Medical societies are slowly providing more CME (continuing medical education) to doctors on cannabis, however, that educational content tends to be slanted toward risk mitigation. reported receiving no education about medical marijuana in medical school or residency. We have a ways to go,” Tan said.
There is a shift happening in this country, away from liberal policies, including drug policy reforms. This language is being re-ushered in by the new Administration and supported by the anti-cannabis members of Congress who are now chairing every committee in the House and Senate essential to advancing cannabis policy.
The initiative also created the Denver Psilocybin Policy Review Panel (“Panel”), which was required to report back to the City on the public safety and other impacts of decriminalization. The City should produce educational public service announcements to inform the public about safety, responsible use, and available risk reduction services.
At the same time, the bill would redirect tax revenue from a legal industry towards various programs that redress harms from the War on Drugs, while also increasing and improving public education and treatment programs geared towards responsible use, reducing overdoses, and saving lives. of the state’s population.
clinical data, and preparation of CTD/DMF/QOS/SmPC where required. Ensure that scientific data supporting submissions are following domestic and international regulations and all relevant guidelines and policies. Qualifications and Education Requirements. Proficiency in English; additional languages are an asset.
“As we collectively analyze and respond to emerging issues in the cannabis industry, we will continue to be the preeminent voice in cannabis regulatory policy.”. Public Health and Data Monitoring. Public Education. Social and Economic Equity. Medical Use and Research. Packaging, Labeling, and Advertising. Cannabinoid Hemp.
Quest Diagnostics started analyzing yearly workplace drug testing data 25 years ago in 1988, and the result of their recent study was published on May 18. However, it is important to note that Quest Diagnostics amphetamines data does not separate prescribed medications like Adderall from illicit drug use. in 2021 and 4.3%
Radicle Science, a healthtech B-corp that validates natural products, launched the Radicle ACES (Advancing CBD Education and Science) study. The study will utilize Radicle Science’s data analytics platform and a virtual, direct-to-consumer model to deliver objective health outcome data across diverse populations and conditions.
HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. E-commerce sales of CBD in the U.S. Consumers spent roughly $31.3
Building the bridge between brands and the marketplace through testing and the importance of good data. If left to their own devices in Cannabis, a mixed bag of state regulations will continue to confuse the market as they rush to implement policies that are challenging for business and almost impossible for the consumer to understand.
A study investigated psilocybin’s effect on alcohol addiction, the FDA outlined best practices for future psychedelic research, and the NCAA is inching toward cannabis policy change. Instead of doling out suspensions and bans, the CSMAS suggests using education instead. Let’s dive into this week’s canna-news.
The nature of the position involves designing application receipt and review processes, review of detailed license and renewal applications, preparation of complaints cases for investigations, preparation of investigations cases for disposition, and oversight of vendor data systems for complex laboratory, seed-to-sale tracking, and complaints.
Marijuana policies in the United States have become more permissive, motivating research on demographic and policy-based differences in behaviors and attitudes towards driving after marijuana use. Marijuana policies in the United States (U.S.) Introduction.
Among the conclusions of this study was the somewhat dire message that: Persistent cannabis use was associated with neuropsychological decline broadly across domains of functioning, even after controlling for years of education. Closer examination of the data revealed a number of important traits that influenced outcomes.
Insurance Journal reports… There’s a shortage of carriers offering insurance to cannabis businesses in numerous states, causing these businesses to pay more for policies or go underinsured. They’ve also had presentations offering data from the state’s seed-to-sale tracking system, and panels on insurance products and forms.
These views underscore the continued need for education about the potential addictive properties of both substances and technology. This disparity underscores the urgent need for more robust public education about the availability and application of naloxone. Legalization efforts and public education campaigns are driving this shift.
(“WM Technology” or the “Company”) (Nasdaq: MAPS), a leading technology and software infrastructure provider to the cannabis industry, has released its first data and insights report, titled ‘Cannabis in America’. According to Weedmaps’ orders data, orders in H1 2021 increased by 55%, compared to H1 2020.
A new cannabis coalition made up of a wide variety of national corporations, including tobacco and alcohol firms, launched today with the purpose of influencing policy and potentially shaping the first federal cannabis regulations. Any one of which is enough to make anybody pause before they go forward with legalization.
After months of development, my partner and I built and successfully launched the beta for our cannabis data-analytics software, Jade Insights. It’s a software platform that helps cannabis businesses augment their process by providing insights for data-backed decision-making. Policy Associate, Drug Policy Alliance , Washington, D.C.
The bill would appropriate $2 million to a Cannabis Control Commission to launch administration of the law, with “priorities for the allocation of the remaining funds subject to appropriation,” starting with $100,000 annually to the Department of Safety for a drug monitoring initiative and data collection on health impacts.
… Our findings highlight important opportunities to support hospice providers and their patients through education and the development of policies.” Wide variations in MC documentation and education practices between hospices were noted.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content